CIR Panel’s ‘Ethereal’ Role In Cosmetics Regulation Not Clarified By MoCRA

While other legislative proposals to update US cosmetics regulations would have included FDA ingredient review or codified reviews from the CIR Expert Panel for Cosmetic Ingredient Safety, the Modernization of Cosmetic Regulations Act of 2022 does not. Panelists, industry and FDA reps discussed implications for CIR at the 5-6 March meeting of the group’s independent expert panel.

The Modernization of Cosmetic Regulations Act of 2022 does not create a framework for systematic cosmetic ingredient review at the US Food and Drug Administration, as other cosmetics reform proposals would have, but does include new requirements for substantiating the safety of cosmetic products.

More from Legislation

More from Policy & Regulation